Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient
نویسندگان
چکیده
منابع مشابه
Tardive Dyskinesia: Treatment with Aripiprazole
Tardive dyskinesia is characterized by choreiform movements, or rhythmic abnormal involuntary movements of the face, mouth, tongue, trunk, and limbs. It is frequently associated with the use of neuroleptic medications. The choreiform movements are irreversible in some patients, even after the drug is withdrawn. Although no reliable treatment for tardive dyskinesia exists, atypical antipsychotic...
متن کاملa cross-comparative dtudy between two textbook series in terms of the presentation of politeness
چکیده ندارد.
15 صفحه اولA Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow Up
Tardive dyskinesia (TD) is arguably the most serious and potential irreversible side effect of antipsychotic medication. Traditionally first generation antipsychotics are the neuroleptics considered to have higher risk of TD as compared to second and third generation antipsychotics. Aripiprazole is a third-generation antipsychotic with a novel mechanism of action. Risk of developing TD with use...
متن کاملEfficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report.
Tardive syndromes (TDS) are a group of movement disorders. Tardive dyskinesia is the best-known type of TDS. Another type of TDS is tardive dystonia. TDS cause body parts to move uncontrollably. Tardive dyskinesia and tardive dystonia are caused by dopamine receptor blocking agents, mostly antipsychotics but occasionally antidepressants (Jankovic 1995). However, tardive dystonia associated with...
متن کاملA Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months. T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Primary Care Companion For CNS Disorders
سال: 2012
ISSN: 2155-7780
DOI: 10.4088/pcc.11l01315